TGA, Australia Recalls Sartans due to Azide Impurity
|
|
0
|
257
|
October 15, 2021
|
Summary of current Nitrosamine Regulatory scenario
|
|
0
|
214
|
October 15, 2021
|
FDA alerts to a voluntary recall of varenicline - What do we know?
|
|
17
|
960
|
September 30, 2021
|
So… the Nitrosamines crisis unfolding into judicial consequences
|
|
0
|
230
|
September 13, 2021
|
CDER conducts Lab & Clinical studies to evaluate NDMA production from Ingested Ranitidine products
|
|
0
|
159
|
September 8, 2021
|
MHRA recalls Metformin Oral solution
|
|
14
|
296
|
September 3, 2021
|
Brazilian focus on Nitrosamines
|
|
0
|
192
|
August 26, 2021
|
FDA rejects the extension of deadlines for submission of Nitrosamine Risk Assessments
|
|
0
|
170
|
August 11, 2021
|
Health Canada Safety Recall - NMOA
|
|
3
|
259
|
July 13, 2021
|
European supplier recalling due AZBT?
|
|
11
|
346
|
July 9, 2021
|
Nitrosamine Implementation Oversight Group (NIOG) Workplan and topics for QWP & SWP IP Meetings
|
|
0
|
154
|
April 15, 2021
|
EU Nitrosamines Oversight Group Identifies Priority Topics
|
|
0
|
139
|
April 15, 2021
|